Xueming Wu

Xueming Wu is a highly experienced professional in pharmaceutical formulation and product development, currently serving as the Director of Formulation R&D at Humanwell Pharmaceutical US, Inc. since 2020. Wu has a robust background with prior roles including Product Development Manager at Aucta Pharmaceuticals Inc. and Sr. Scientist at Par Pharmaceutical. Expertise includes leading the development of various drug formulations such as ANDAs, 505b2 applications, IR/ER tablets, and complex injection systems. Wu's academic credentials include a PhD in Pharmaceutical Sciences from Josai University and multiple degrees in the field from Shenyang Pharmaceutical University. Previous research experiences involve drug delivery systems and cancer imaging technology, showcasing a strong foundation in both practical and theoretical aspects of pharmaceutical sciences.